基本資料
種類: ETF
費用比率%: 0.60
資產淨值: 32.73
成立日期: 11/12/2017
 
分析
市值分佈:
42.31%
大市值
2.51%
中市值
0.81%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 01/08/2026 05:19) 總持有投資項目: 151  
0%
 
100%
     10大 (16.92%)
代號 名稱 佔比% 持有日期
CDNACareDx0.0828/07/2026
PGENPrecigen0.0828/07/2026
ORICOric Pharmaceuticals0.0728/07/2026
CHRWC.H. Robinson Worldwide0.0729/07/2026
ZBIOZenas Biopharma Inc.0.0730/06/2026
JBIOJade Biosciences Inc0.0730/06/2026
PURRHyperliquid Strategies Inc0.0729/07/2026
ABSIAbsci Corp0.0728/07/2026
VORVor Biopharma Inc0.0729/07/2026
AVBPArriVent BioPharma0.0730/06/2026
SNPSSynopsys0.0628/07/2026
SIONSionna Therapeutics Inc0.0630/06/2026
GERNGeron Corp0.0630/06/2026
RIGLRigel Pharmaceuticals Inc0.0530/06/2026
ALLOAllogene Therapeutics0.0530/06/2026
SANASana Biotechnology0.0530/06/2026
MPWRMonolithic Power Systems0.0528/07/2026
NXPINXP Semiconductors NV0.0529/07/2026
COOCooper Companies (The)0.0530/06/2026
IRWDIronwood Pharmaceuticals0.0530/06/2026
  1    2    3    4    5   6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.